MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
Open accessThe DOI matches its Crossref record; 48 of the 53 references it cites were found in a registry or an index.
Abstract
The renal proximal tubule reabsorbs 90% of the filtered glucose load through the Na + -coupled glucose transporter SGLT2, and specific inhibitors of SGLT2 are now available to patients with diabetes to increase urinary glucose excretion. Using expression cloning, we identified an accessory protein, 17 kDa membrane-associated protein (MAP17), that increased SGLT2 activity in RNA-injected Xenopus oocytes by two orders of magnitude. Significant stimulation of SGLT2 activity also occurred in opossum kidney cells cotransfected with SGLT2 and MAP17. Notably, transfection with MAP17 did not change the quantity of SGLT2 protein at the cell surface in either cell type. To confirm the physiologic relevance of the MAP17–SGLT2 interaction, we studied a cohort of 60 individuals with familial renal glucosuria. One patient without any identifiable mutation in the SGLT2 coding gene ( SLC5A2 ) displayed homozygosity for a splicing mutation (c.176+1G>A) in the MAP17 coding gene ( PDZK1IP1 ). In the proximal tubule and in other tissues, MAP17 is known to interact with PDZK1, a scaffolding protein linked to other transporters, including Na + /H + exchanger 3, and to signaling pathways, such as the A-kinase anchor protein 2/protein kinase A pathway. Thus, these results provide the basis for a more thorough characterization of SGLT2 which would include the possible effects of its inhibition on colocalized renal transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Expression cloning and cDNA sequencing of the Na+/glucose co-transporter
Hediger, M. A., Coady, M. J., Ikeda, T. S., & Wright, E. M. (1987) · Nature · doi:10.1038/330379a0 · Cited by 1,004
Self-citationRenal Na+-glucose cotransporters
Wright, E. M. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.1.f10 · Cited by 583
MOLECULAR PHYSIOLOGY OF INTESTINAL N + /H + EXCHANGE
Zachos, N. C., Tse, M., & Donowitz, M. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.031103.153004 · Cited by 365
Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target
Santer, R., & Calado, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04010609 · Cited by 343
Self-citationFunctional expression of sodium-glucose transporters in cancer
Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 329
Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria
Santer, R., Kinner, M., Lassen, C. L., Schneppenheim, R., Eggert, P., Bald, M., Brodehl, J., Daschner, M., Ehrich, J. H. H., Kemper, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092790.89332.d2 · Cited by 305
Self-citationGlucose transport by human renal Na + / d -glucose cotransporters SGLT1 and SGLT2
Hummel, C. S., Lu, C., Loo, D. D. F., Hirayama, B. A., Voss, A. A., & Wright, E. M. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00388.2010 · Cited by 270
Interaction of the Type IIa Na/Pi Cotransporter with PDZ Proteins
Gisler, S. M., Stagljar, I., Traebert, M., Bacic, D., Biber, J., & Murer, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008745200 · Cited by 243
Sabolić, I., Vrhovac, I., Eror, D. B., Gerasimova, M., Rose, M., Breljak, D., Ljubojević, M., Brzica, H., Sebastiani, A., Thal, S. C., et al. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00450.2011 · Cited by 195
Gisler, S. M., Pribanic, S., Bacic, D., Forrer, P., Gantenbein, A., Sabourin, L. A., Tsuji, A., Zhao, Z.-S., Manser, E., Biber, J., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00266.x · Cited by 188
Research works printed but not linked: 1
- Santer, 2000, The molecular basis of renal glucosuria: mutations in the gene for a renal glucose transporter (SGLT2)., J Inherit Metab Dis, 23, 178
Cited by
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 589
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
Vallon, V., & Verma, S. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-095920 · Cited by 516
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
Ghezzi, C., Loo, D. D. F., & Wright, E. M. (2018) · Diabetologia · doi:10.1007/s00125-018-4656-5 · Cited by 348
“Michael Coady and his colleagues recently elucidated the reason for low SGLT2 expression in oocytes with the discovery that co-expression of MAP17 was required [41, 42].”
Background
Metadata
- Authors
- Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., Lussier, Y., Dumayne, C., Bichet, D. G., & Lapointe, J.-Y.
- Affiliations
- Physics Department & Groupe d’étude des protéines membranaires,
- Departement of Molecular and Integrative Physiology & Groupe d’étude des protéines membranaires, and
- University Medical Center Hamburg-Eppendorf (DE)
- University of Lisbon (PT)
- Hôpital du Sacré-Cœur de Montréal (CA)
- Corresponding author
- Coady, Michael J.
- Sasseville, Louis J.
- Lapointe, Jean-Yves
- Venue
- Journal of the American Society of Nephrology
- Published
- 2016-06-10
- Volume
- 28
- Issue
- 1
- Pages
- 85-93
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC5198278
- OpenAlex
- W2409027410
- Cited by
- 106
- References
- 53
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 8 · 2023: 18 · 2022: 14 · 2021: 12 · 2020: 10 · 2019: 7 · 2018: 8 · 2017: 6 · 2016: 3
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- MAP17, PDZK1IP1, SGLT2, Na+/glucose cotransporter, renal glucose reabsorption, proximal tubule, renal glycosuria, SLC5A2, splicing mutation, protein-protein interaction, PDZK1, protein kinase A, SGLT2 inhibitors, diabetes mellitus
- MeSH terms
- Animals, Cells, Cultured, Glycosuria, Renal, Humans, Kidney, Kidney Tubules, Proximal, Membrane Proteins, Mutation, Opossums, Sodium-Glucose Transporter 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2. https://app.cochat.ai/papers/10.1681/asn.2015111282
- The paper
- Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., Lussier, Y., Dumayne, C., Bichet, D. G., & Lapointe, J.-Y. (2017). MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2015111282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.